Atorvastatin, lovastatin, simvastatin with imatinib and nilotinibDDI: moderate; monitor for increased statin adverse effects (e.g., myopathy)Effect: increase serum level of statinMechanism: CYP3A4 inhibition. This evidence concerns the gene CYP3A4 and myopathy.